Insight Molecular Diagnostics Inc. financial data

Symbol
IMDX on Nasdaq
Location
Nashville, TN
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 308% % 206%
Quick Ratio 6.5% %
Debt-to-equity -1,970.15% % -688.38%
Return On Equity 2,394% %
Return On Assets -128.02% % -115.73%
Operating Margin -1,392.91% % 77%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28,664,437 shares 70%
Common Stock, Shares, Outstanding 28,625,405 shares 114%
Entity Public Float $24,600,000 USD 31%
Common Stock, Value, Issued $368,524,000 USD 13%
Weighted Average Number of Shares Outstanding, Basic 32,033,000 shares 134%
Weighted Average Number of Shares Outstanding, Diluted 32,033,000 shares 134%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $4,402,000 USD 521%
Cost of Revenue $1,964,000 USD 231%
Research and Development Expense $12,340,000 USD 22%
Selling and Marketing Expense $5,254,000 USD 58%
General and Administrative Expense $10,866,000 USD 16%
Operating Income (Loss) $-61,316,000 USD -40.66%
Nonoperating Income (Expense) $538,000 USD 20%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $-60,663,000 USD -144.07%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $-60,778,000 USD -40.87%
Earnings Per Share, Basic -3 USD/shares 35%
Earnings Per Share, Diluted -3 USD/shares 35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $18,692,000 USD 456%
Accounts Receivable, after Allowance for Credit Loss, Current $258,000 USD 23%
Inventory, Net $471,000 USD 103%
Assets, Current $21,389,000 USD 346%
Property, Plant and Equipment, Net $5,802,000 USD -6.31%
Intangible Assets, Net (Excluding Goodwill) $14,600,000 USD -74.17%
Other Assets, Noncurrent $672,000 USD -3.86%
Assets $43,937,000 USD -37.43%
Accounts Payable, Current $1,056,000 USD 21%
Accrued Liabilities, Current $2,228,000 USD 17%
Liabilities, Current $7,660,000 USD -15.73%
Liabilities $53,133,000 USD -12.18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $86,000 USD 51%
Retained Earnings (Accumulated Deficit) $-377,806,000 USD -19.17%
Stockholders' Equity Attributable to Parent $-9,196,000 USD -194.7%
Liabilities and Equity $43,937,000 USD -37.43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-5,858,000 USD -52.95%
Net Cash Provided by (Used in) Financing Activities $28,558,000 USD
Net Cash Provided by (Used in) Investing Activities $-307,000 USD -1,179.17%
Common Stock, Shares Authorized 230,000,000 shares 0%
Common Stock, Shares, Issued 28,625,405 shares 114%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $22,393,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $24,000 USD
Deferred Tax Assets, Valuation Allowance $64,436,000 USD -4.28%
Deferred Tax Assets, Gross $69,116,000 USD -16.37%
Operating Lease, Liability $1,953,000 USD -31.11%
Payments to Acquire Property, Plant, and Equipment $307,000 USD 1,179%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-60,749,000 USD -40.89%
Lessee, Operating Lease, Liability, to be Paid $2,166,000 USD -34.36%
Lessee, Operating Lease, Liability, to be Paid, Year Two $696,000 USD -41.12%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,182,000 USD 3.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $213,000 USD -54.19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards $49,953,000 USD -19.12%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $1,100,000 USD -52.17%
Operating Lease, Payments $281,000 USD 3.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $29,000 USD -67.04%
Depreciation, Depletion and Amortization $2,197,000 USD 72%
Deferred Tax Assets, Net of Valuation Allowance $4,680,000 USD -69.48%
Share-based Payment Arrangement, Expense $1,997,000 USD 15%